BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF AND Diagnosis
25 results:

  • 1. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
    Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
    Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
    [No Abstract]    [Full Text] [Related]  

  • 2. Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
    Coupier A; Gallien Y; Boillot O; Walter T; Guillaud O; Vallin M; Thimonier E; Erard D; Dumortier J
    Clin Transplant; 2023 Jan; 37(1):e14841. PubMed ID: 36394373
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
    Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
    Chiaretti S; Messina M; Della Starza I; Piciocchi A; Cafforio L; Cavalli M; Taherinasab A; Ansuinelli M; Elia L; Albertini Petroni G; La Starza R; Canichella M; Lauretti A; Puzzolo MC; Pierini V; Santoro A; Spinelli O; Apicella V; Capria S; Di Raimondo F; De Fabritiis P; Papayannidis C; Candoni A; Cairoli R; Cerrano M; Fracchiolla N; Mattei D; Cattaneo C; Vitale A; Crea E; Fazi P; Mecucci C; Rambaldi A; Guarini A; Bassan R; Foà R
    Haematologica; 2021 Jun; 106(6):1559-1568. PubMed ID: 32467145
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
    Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
    Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.
    Aoe M; Ishida H; Matsubara T; Karakawa S; Kawaguchi H; Fujiwara K; Kanamitsu K; Washio K; Okada K; Shibakura M; Shimada A
    Int J Lab Hematol; 2018 Aug; 40(4):427-436. PubMed ID: 29575541
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.
    Núñez-Enríquez JC; Bárcenas-López DA; Hidalgo-Miranda A; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Solis-Labastida KA; Martínez-Morales GB; Sánchez-Muñoz F; Espinoza-Hernández LE; Velázquez-Aviña MM; Merino-Pasaye LE; García Velázquez AJ; Pérez-Saldívar ML; Mojica-Espinoza R; Ramírez-Bello J; Jiménez-Morales S; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):644-655. PubMed ID: 28476192
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ebf1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
    Schwab C; Ryan SL; Chilton L; Elliott A; Murray J; Richardson S; Wragg C; Moppett J; Cummins M; Tunstall O; Parker CA; Saha V; Goulden N; Vora A; Moorman AV; Harrison CJ
    Blood; 2016 May; 127(18):2214-8. PubMed ID: 26872634
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
    Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
    Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A capture-sequencing strategy identifies IRF8, ebf1, and APRIL as novel IGH fusion partners in B-cell lymphoma.
    Bouamar H; Abbas S; Lin AP; Wang L; Jiang D; Holder KN; Kinney MC; Hunicke-Smith S; Aguiar RC
    Blood; 2013 Aug; 122(5):726-33. PubMed ID: 23775715
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
    Lewinshtein D; Gulati R; Nelson PS; Porter CR
    BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.
    Harvey RC; Mullighan CG; Wang X; Dobbin KK; Davidson GS; Bedrick EJ; Chen IM; Atlas SR; Kang H; Ar K; Wilson CS; Wharton W; Murphy M; Devidas M; Carroll AJ; Borowitz MJ; Bowman WP; Downing JR; Relling M; Yang J; Bhojwani D; Carroll WL; Camitta B; Reaman GH; Smith M; Hunger SP; Willman CL
    Blood; 2010 Dec; 116(23):4874-84. PubMed ID: 20699438
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
    Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
    Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Increased risk of second primary cancers after a diagnosis of melanoma.
    Bradford PT; Freedman DM; Goldstein AM; Tucker MA
    Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.
    Yang JJ; Bhojwani D; Yang W; Cai X; Stocco G; Crews K; Wang J; Morrison D; Devidas M; Hunger SP; Willman CL; Raetz EA; Pui CH; Evans WE; Relling MV; Carroll WL
    Blood; 2008 Nov; 112(10):4178-83. PubMed ID: 18768390
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
    Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
    Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
    Kunthur A; Wiernik PH; Dutcher JP
    Am J Hematol; 2006 Apr; 81(4):271-80. PubMed ID: 16550521
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
    Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
    J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.